Title for MeetingAbstracts
Alphabetical listing of titles
Zidovudine postexposure prophylaxis. The Italian Study Group on Occupational Risk of HIV Infection.
Zidovudine prophylaxis after occupational exposure to HIV in health care workers.
Zidovudine prophylaxis for health care workers following occupational HIV exposure.
Zidovudine prophylaxis for persons with accidental percutaneous blood exposure: a decision analysis.
Zidovudine prophylaxis for the prevention of HIV vertical transmission in the hospital clinic of Barcelona.
Zidovudine reduces HIV-1 perinatal transmission even if only the oral component administered to pregnant women is used.
Zidovudine resistance after vertical transmission of HIV-1.
Zidovudine resistance and associated factors among HIV-infected Canadian children.
Zidovudine resistance and HIV-1 load in multiple autopsy tissues of AIDS patients.
Zidovudine resistance at entry to ACTG protocol 116B/117 predicted HIV-1 disease progression.
Zidovudine sensitivity of HIV during the development from the asymptomatic stage to AIDS.
Zidovudine serum levels and half-life in patients on chronic maintenance hemodialysis.
Zidovudine susceptibility among asymptomatic HIV+ persons.
Zidovudine therapy (AZT Rx) delays progression to AIDS in intravenous drug users (IVDUs) with oral thrush (OT).
Zidovudine therapy can reverse the antigen receptor signaling defect in CD4+ T cells from HIV-infected patients.
Zidovudine therapy for HIV encephalopathy.
Zidovudine therapy in homosexual/bisexual patients with AIDS-related complex (ARC) in Australia.
Zidovudine therapy in pediatric patients: Report on 622 children enrolled in a treatment IND.
Zidovudine therapy of asymptomatic HIV infected persons with less than 500 CD4+ cells/mm3 - ACTG protocol 019.
Zidovudine to decrease mother-to-child transmission of HIV-1: a phase II study in West Africa, 1995-1996 (ANRS 049a).
Zidovudine treatment and incidence of progressive multifocal leukoencephalopathy (PML) in AIDS patients.
Zidovudine treatment in 100 consecutive patients with AIDS or AIDS related complex.
Zidovudine treatment in adolescent hemophiliac children with HIV infection.
Zidovudine treatment in children with symptomatic HIV infection.
Zidovudine treatment in early HIV infection: laboratory studies.
Zidovudine treatment in HIV-infected intravenous drug users. Compliance with long-term treatment and efficacy.
Zidovudine treatment of HIV infection: clinical & immunological evaluation.
Zidovudine treatment versus placebo in primary HIV infection; preliminary results.
Zidovudine usage: patient compliance and factors.
Zidovudine use after occupational exposure to HIV-infected blood.